SCHEMBL6622167

SCHEMBL6622167

CCOC(=O)Cc1nc2ccc(Cl)nn2c1C

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
TDP1 Q9NUW8 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
MAPT P10636 3/20 0.42
POLB P06746 1/20 0.42
RECQL P46063 1/20 0.41
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SLC2A2 P11168 1/20 0.39
RAB9A P51151 1/20 0.38
PKM P14618 1/20 0.38
HTT P42858 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6620137 0.83 KDM4E (0.38) KDM4ETDP1L3MBTL1SMN1; SMN2MAPT
SCHEMBL6615852 0.78 PDE4A (0.50) KDM4ESMN1; SMN2MAPTALDH1A1KMT2A
SCHEMBL18378571 0.78 PDE10A (0.43) KDM4ESMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL15690112 0.77 PDE10A (0.44) KDM4ESMN1; SMN2ALDH1A1
SCHEMBL6617769 0.77 HPGD (0.47) KDM4ESMN1; SMN2MAPTALDH1A1RAB9A
SCHEMBL6620317 0.74 TSHR (0.37) KDM4ETDP1L3MBTL1SMN1; SMN2MAPT
SCHEMBL6618313 0.74 KDM4E (0.44) KDM4ESMN1; SMN2MAPTPOLBRECQL
SCHEMBL953671 0.73 MAPK1 (0.52) KDM4ESMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL3742052 0.73 RAB9A (0.44) KDM4ESMN1; SMN2MAPTPOLBRECQL
SCHEMBL12798449 0.73 RAB9A (0.44) KDM4ESMN1; SMN2MAPTRECQLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979231-B1 CONDENSED PYRIDAZINE DERIVATIVES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-11-24 EP disclosed
EP-1123936-B1 FUSED PYRIDAZINE DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-12-10 EP disclosed
US-6627630-B1 Preventing or treating allergic skin diseases such as contact dermatitis, pruritus, dried dermatitis, acute urticaria prurigo and antiallergins TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1243271-A1 NASAL DROPS CONTAINING FUSED PYRIDAZINE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2002-09-25 EP disclosed
EP-1123936-A1 FUSED PYRIDAZINE DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-08-16 EP disclosed
US-6248740-B1 FOR SUPPRESSION OF HISTAMINE OR EOSINOPHIL CHEMOTAXIS TO TREAT ASTHMA; ANTIALLERGENIC TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-19 US disclosed
EP-0979231-A1 CONDENSED PYRIDAZINE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 2000-02-16 EP disclosed
WO-1998049167-A1 CONDENSED PYRIDAZINE DERIVATIVES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-11-05 WO disclosed